[HTML][HTML] Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin …
I Greco, AP Emborg, B Jana, N Molchanova, A Oddo… - Scientific Reports, 2019 - nature.com
… The aims of this study were to (i) characterize the antimicrobial activity of the novel
peptide-peptoid hybrid B1 against a large collection of two common dog integumentary pathogens S. …
peptide-peptoid hybrid B1 against a large collection of two common dog integumentary pathogens S. …
Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens
JE Nielsen, MA Alford, DBY Yung… - ACS infectious …, 2022 - ACS Publications
… to their class and are presented as groups of peptoids and peptides (A) or lipopeptoids (B). …
We used these peptoids to treat ESKAPE pathogens and investigated their activity against …
We used these peptoids to treat ESKAPE pathogens and investigated their activity against …
Antimicrobial β‐peptides and α‐peptoids
T Godballe, LL Nilsson, PD Petersen… - Chemical biology & …, 2011 - Wiley Online Library
… the peptides to adhere to the surface of the bacteria through … the β-peptide and the N-substituted
glycine (peptoid) strategy will be covered within this review. The antibacterial β-peptides …
glycine (peptoid) strategy will be covered within this review. The antibacterial β-peptides …
Protein-mimetic peptoid nanoarchitectures for pathogen recognition and neutralization
… Compared to peptides, peptoids feature a backbone with side chains appended to the …
According to the literature, enclosing bacteria with peptoid nanosheets inhibits their growth …
According to the literature, enclosing bacteria with peptoid nanosheets inhibits their growth …
Antimicrobial Peptide–Peptoid Hybrids with and without Membrane Disruption
E Bonvin, H Personne, T Paschoud… - ACS infectious …, 2023 - ACS Publications
… peptoids (EB8). Finally, we prepared EB9 and EB10 with alternating peptide and peptoid
building blocks and full peptoid … Interactions of peptide–peptoid hybrids with bacterial outer and …
building blocks and full peptoid … Interactions of peptide–peptoid hybrids with bacterial outer and …
Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials
RM Green, KL Bicker - International journal of antimicrobial agents, 2020 - Elsevier
… pathogens. Of particular interest is the improved efficacy of MG10 against Gram-negative
bacteria, which are pathogens … potential of peptoid mimics of peptides as antimicrobial agents, …
bacteria, which are pathogens … potential of peptoid mimics of peptides as antimicrobial agents, …
A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents
… AMPs capable of combating bacterial pathogens. Initial studies … of the bacteria8b with a
representative cyclic peptoid chosen … for solid-phase peptoid and peptide syntheses are 0.49 and …
representative cyclic peptoid chosen … for solid-phase peptoid and peptide syntheses are 0.49 and …
β-Peptoid foldamers at last
JS Laursen, J Engel-Andreasen… - Accounts of Chemical …, 2015 - ACS Publications
… bacterial infections have been considered minor medical challenges. However, development
of pathogenic … (44) On the basis of the finding that some of our α-peptide/β-peptoids were …
of pathogenic … (44) On the basis of the finding that some of our α-peptide/β-peptoids were …
Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis
R Kapoor, PR Eimerman, JW Hardy… - Antimicrobial agents …, 2011 - Am Soc Microbiol
… on a “biomimetic” peptide backbone … bacteria and fungi, was used as a positive control,
whereas the cationic and aliphatic dodecamer peptoid 1-Nssb, which is inactive against bacteria, …
whereas the cationic and aliphatic dodecamer peptoid 1-Nssb, which is inactive against bacteria, …
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
NP Chongsiriwatana, JA Patch… - Proceedings of the …, 2008 - National Acad Sciences
… antimicrobial peptides (AMPs) defend a wide array of organisms against bacterial pathogens
… antibiotics, because few bacteria have evolved resistance to them (1–3). Many AMPs kill …
… antibiotics, because few bacteria have evolved resistance to them (1–3). Many AMPs kill …